Alisha Wursten
Family · Salt Lake City, UTNPI 1457847675
Payments from drug & device makers
Across 128 payments — averaging $20.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$404
- Teva Pharmaceuticals USA, Inc.$336
- Supernus Pharmaceuticals, Inc.$328
- Johnson & Johnson$295
- Neurocrine Biosciences, Inc.$260
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$150
- plus $887 from 14 others
What the payments were for
- Food & beverage$2,659100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $404 |
| Teva Pharmaceuticals USA, Inc. | 29 | $336 |
| Supernus Pharmaceuticals, Inc. | 6 | $328 |
| Johnson & Johnson | 12 | $295 |
| Neurocrine Biosciences, Inc. | 9 | $260 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $150 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| Axsome Therapeutics, Inc. | 7 | $127 |
| Corium, LLC | 5 | $103 |
| Lundbeck LLC | 4 | $89 |
| Idorsia Pharmaceuticals US Inc | 5 | $88 |
| Alkermes, Inc. | 4 | $77 |
| Ironshore Pharmaceuticals Inc. | 3 | $70 |
| Tris Pharma Inc | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Indivior Inc. | 2 | $32 |
| Biogen | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Braeburn Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$252
How this compares
$2,659 in reported general payments places this provider in the 85th percentile of 1,460 family providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lorazepam | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Other family in Salt Lake City
- Katrina BawdenSalt Lake City$446K
- Cortnee RomanSalt Lake City$374K
- Jared ThorleySalt Lake City$368K
- Mary SteinbackSalt Lake City$189K
- Jennalyn MayeuxSalt Lake City$151K
- Kacie Doyle-DelgadoSalt Lake City$80K
- Melonie ThompsonSalt Lake City$45K
- Michelle LitchmanSalt Lake City$44K
- Keisa LynchSalt Lake City$39K
- Christina CardonSalt Lake City$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.